Pipeline for New Medicine
New Bio Medicine
| Project Title | Effective in | R&D | Non-clinical | Clinical Trial Phase 1 | Clinical Trial Phase 2 | Clinical Trial Phase 3 |
|---|---|---|---|---|---|---|
|
HL161
Novel Anti-FcRn Antibody with Molecular Improvement DownLoad |
autoimmune diseases | |||||
|
HL036 (jointly developed with Daewoong Pharmaceutical) Anti-TNF New Bio Ophthalmic Solution DownLoad |
dry eye disease | |||||
|
HL186
Immuno-oncology |
recurrent/ intractable cancer |
|||||
|
HL187
Immuno-oncology |
recurrent/ intractable cancer |
New Advanced Medicine
| Project Title | Effective in | R&D | Non-clinical | Clinical Trial Phase 1 | Clinical Trial Phase 2 | Clinical Trial Phase 3 |
|---|---|---|---|---|---|---|
|
HL040
Advanced Composite Medicine for Hypertension-Dyslipidemia |
ypertension · hyperlipidemia |
|||||
|
HL068
Advanced Composite Medicine for Hypertension |
hypertension | |||||
|
HL018
Advanced Medicine with verified safety for obesity cure |
obesity |
New Synthetic Medicine
| Project Title | Effective in | R&D | Non-clinical | Clinical Trial Phase 1 | Clinical Trial Phase 2 | Clinical Trial Phase 3 |
|---|---|---|---|---|---|---|
|
IM156 (developed by IMMUNOMET) Cancer metabolism |
anticancer |